Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 11324708 Niclosamide formulations for treating disease
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
Date Filed
May 25, 2021
Date of Patent
May 10, 2022
Patent Application Number
17330067
Patent Citations
US Patent 10562864 Chemical modulators of immune checkpoints and therapeutic use
US Patent 10744103 Methods and compositions for treating conditions associated with an abnormal inflammatory responses
US Patent 10758553 Antibacterial use of halogenated salicylanilides
US Patent 10772854 Methods and compositions for treating conditions associated with an abnormal inflammatory response
US Patent 10857164 Halogenated salicylanilides for treating
US Patent 11045434 Niclosamide formulations for treating disease
US Patent 10980756 Methods of treatment
US Patent 11147779 Therapeutic agent for phosphodiesterase inhibition and its related disorders
US Patent 10189797 Chemical modulators of immune checkpoints and therapeutic use
US Patent 10463680 Halogenated salicylanilides for treating clostridium infections
Patent Citations Received
US Patent 11529361 Halogenated salicylanilides for treating
Patent Jurisdiction
United States Patent and Trademark Office
Patent Number
11324708
Patent Primary Examiner
Gigi G Huang
Find more entities like US Patent 11324708 Niclosamide formulations for treating disease
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE